Rationale: The healthcare industry sometimes makes payments to physicians for
nonresearch and research purposes in the United States. Objectives: We aimed to evaluate …

There are prevalent financial relationships between dermatologists and pharmaceutical
companies in Japan. However, little was known about the extent of whole picture of the …

PURPOSE: Many oncologists have relationships with industry. Previous work has shown
that these payments are usually modest; however, there exist a subset of medical …

Much has been written recently on gender disparities in medicine and the negative
outcomes that result for women. The impetus for examining these disparities is manifold …

Objectives Gender inequities in editorial board representation and physician compensation
are well documented, but few studies have focused on how editors of journals are …

It has been widely reported that women are underrepresented in leadership positions within
academic medicine. This study aimed to assess trends in women representation as principal …

Background In 2016, orthopaedic surgeons received nearly USD 300 million from industry,
with the top 10% of recipients making more than 95% of the total amount. The degree to …

One perhaps overlooked area of gender disparity is the under-representation of women in
industry advisory boards, often referred to as ad boards. Pharmaceutical, biotechnology, and …

Introduction Although hospitals are key health service providers, their financial ties to drug
companies are little understood. We examine non-research pharmaceutical industry …

Purpose: To report the representation of female ophthalmologists receiving private industry
funding from 2015 through 2018, and to compare to previously observed trends. DESIGN …